News and Resources
News and resources
Navigating rough waters: reaching the zero-dose children of Manoka Island
The Manoka Health District, a cluster of hard-to-reach islets in coastal Cameroon, is an immunisation blind spot: more than 90% of kids under two here have never had a single vaccine. Dr Nchinjoh plans to change that.
IFFIm funding contributes to health gains across Africa
IFFIm provides funding for 15% of Gavi’s immunisation programmes across Africa.
How has IFFIm made a difference for Gavi?
Since 2006, IFFIm has contributed approximately US$ 5.2 billion to Gavi. IFFIm support has meant Gavi has been able to provide more life-saving vaccines, faster.
HPV vaccines introduced in four new countries, aided by IFFIm funding
IFFIm funding for Gavi’s ongoing HPV programmes is helping to prevent this deadly cancer in girls and women.
A new vaccine against typhoid rolls out in a flood-devastated province of Pakistan
Armed with vials of Typhoid Conjugate Vaccine, health workers in Balochistan are doing what they can to protect children threatened by a pincer movement of global crises: antimicrobial resistance on the one hand and climate change on the other.
IFFIm returns to market with US$ 500 million 3-year bond
The International Finance Facility for Immunisation Company (IFFIm) today priced a US$ 500 million, 3-year fixed rate bond to provide Gavi, the Vaccine Alliance, with immediately available funding to support routine immunisation in lower-income countries, reaching nearly half the world’s children.
Gavi Annual Progress Report: 2021 was “defining” for IFFIm
From its founding in 2000 to the end of 2021, Gavi has helped to immunise a whole generation – over 981 million children – and prevented more than 16.2 million future deaths, helping to halve child mortality in 73 lower-income countries by the end of 2021. These are a few of the results published in Gavi’s 2021 Annual Progress Report.
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.